ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Name: ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
License: Public Domain

Immatics US, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cancer

refractory cancer, recurrent cancer, solid tumor, adult, cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 366585
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.